1.      American Academy of Ophthalmology. Basic and Clinical Science Course (BCSC), Section 2: Fundamentals and Principles of Ophthalmology. 2022–2023 ed. San Francisco: American Academy of Ophthalmology; 2022.

2.      Bas AY, Demirel N, Koc E, Ulubas Isik D, Hirfanoglu IM, Tunc T, et al. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018;102(12):1711-6.

3.      Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatrics. 2013;131(1):e178-85.

4.      Campbell JP, Kalpathy-Cramer J, Erdogmus D, Tian P, Kedarisetti K, Moleta C, et al. Expert diagnosis of plus disease in retinopathy of prematurity. Ophthalmology. 2016;123(11):2338-44.

5.      Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Chan RVP, Berrocal A, et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. 2021;128(10):e51-68.

6.      Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-94.

7.      Fierson WM; American Academy of Pediatrics Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6):e20183061.

8.      Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al. The incidence and course of retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Pediatrics. 2005;116(1):15-23.

9.      Hartnett ME, Maguluri S. Retinopathy of prematurity and retinal detachment. In: Ryan SJ, editor. Retina. 5th ed. Philadelphia: Elsevier; 2013. p. 2118-25.

10.  Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367(26):2515-26.

11.  Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382(9902):1445-57.

12.  Hong EH, Shin YU, Cho HJ, Yu HG, Lee SJ. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clin Exp Pediatr. 2021;64(11):577-88.

13.  Ji MH, Yu XD, Ma L, Lu Q, Xu XL. Anti-VEGF agents for retinopathy of prematurity: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(2):351-66.

14.  Lim HW, Pershing S, Moshfeghi DM, Heo HM, Haque ME, Lambert SR, et al. Causes of childhood blindness in the United States using the IRIS® Registry (Intelligent Research in Sight). Ophthalmology. 2023;130(9):907-13.

15.  Löfqvist C, Hellgren G, Niklasson A, Engström E, Ley D, Hansen-Pupp I, et al. Low postnatal serum IGF-1 levels are associated with retinopathy of prematurity. Pediatrics. 2006;117(6):1930-8.

16.  Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603-15.

17.  Muether PS, Hoerster R, Kirchhof B, Fauser S. Diode laser photocoagulation for retinopathy of prematurity: long-term results. Br J Ophthalmol. 2010;94(4):452-6.

18.  Padhi TR. Characteristics of posterior zone I retinopathy of prematurity (ROP). Indian J Ophthalmol. 2023;71(5):1612-8.

19.  Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, et al. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010;120(9):3022-32.

20.  Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res. 2004;14 Suppl A:S140-4.

21.  Smith LE. Pathogenesis of retinopathy of prematurity. Semin Neonatol. 2003;8(6):469-73.

22.  Stahl A, Lepore D, de Carvalho J, Fielder A, Fleck B, Reynolds JD, et al. Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial. JAMA. 2022;328(4):348-59.

23.  Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, et al. Ranibizumab versus laser therapy for retinopathy of prematurity (RAINBOW): a randomised, open-label, non-inferiority, phase 3 trial. Lancet. 2019;394(10208):1551-9.

24.  Türk Neonatoloji Derneği, Türk Oftalmoloji Derneği. Türkiye prematüre retinopatisi rehberi 2021 güncellemesi: tanı ve tedavi rehberi. Ankara: Türk Neonatoloji Derneği; 2021.